JASMINE TEAMER: Open Payments
NPI 1760976153 · NEWNAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,022 in 36 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $229 · 2025 $1,022
Food & beverage: $932Education: $90
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $146 |
| Merck Sharp & Dohme LLC | 5 | $138 |
| Paratek Pharmaceuticals, Inc. | 4 | $96 |
| Gilead Sciences, Inc. | 3 | $90 |
| Melinta Therapeutics, LLC | 3 | $72 |
| Napo Pharmaceuticals Inc | 1 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58 |
| Cumberland Pharmaceuticals, Inc. | 2 | $54 |
| ABBVIE INC. | 2 | $54 |
| ViiV Healthcare Company | 2 | $54 |
Products named: NUZYRA, PIFELTRO, Rezzayo, Mytesi, CUVITRU, Cresemba, VIBATIV, Arikayce.
Industry payments across GA — which companies pay providers there.
